Related references
Note: Only part of the references are listed.Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?
Keertan Dheda et al.
RESPIROLOGY (2018)
Cash interventions to improve clinical outcomes for pulmonary tuberculosis: systematic review and meta-analysis
Aaron Richterman et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2018)
Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis
V Cox et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2018)
Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries
A. Trebucq et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2018)
Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses
Faiz Ahmad Khan et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Transmission of Extensively Drug-Resistant Tuberculosis in South Africa
N. Sarita Shah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study
Abdulhalik Workicho et al.
INFECTION AND DRUG RESISTANCE (2017)
Of Testing and Treatment: Implications of Implementing New Regimens for Multidrug-Resistant Tuberculosis
David W. Dowdy et al.
CLINICAL INFECTIOUS DISEASES (2017)
High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?
Romain Ragonnet et al.
BMC INFECTIOUS DISEASES (2017)
Xpert® MTB/RIF for smear-negative presumptive TB: impact on case notification in DR Congo
N. B. Mbonze et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
Riya Moodley et al.
EUROPEAN RESPIRATORY REVIEW (2016)
Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis
P. Isaakidis et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon
C. Kuaban et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis
Emily A. Kendall et al.
LANCET RESPIRATORY MEDICINE (2015)
Treatment Outcomes for Patients with Multidrug-Resistant Tuberculosis in Post-Earthquake Port-au-Prince, Haiti
Macarthur Charles et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2014)
Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries
Jacob Creswell et al.
BMC INFECTIOUS DISEASES (2014)
Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients
K. J. M. Aung et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses
A. Piubello et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline
Andreas H. Diacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Association between HIV/AIDS and Multi-Drug Resistance Tuberculosis: A Systematic Review and Meta-Analysis
Yonatan Moges Mesfin et al.
PLOS ONE (2014)
Multi Drug Resistant Tuberculosis in Mosango, a Rural Area in the Democratic Republic of Congo
Michel Kayomo Kaswa et al.
PLOS ONE (2014)
Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan
S. van den Hof et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Treatment of multidrug-resistant tuberculosis in a remote, conflict-affected area of the Democratic Republic of Congo
L. Shanks et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
Maria Tarcela Gler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
Shama D. Ahuja et al.
PLOS MEDICINE (2012)
Drug-Resistant Tuberculosis Transmission and Resistance Amplification within Families
James A. Seddon et al.
EMERGING INFECTIOUS DISEASES (2012)
Comparison of the Xpert MTB/RIF Test with an IS6110-TaqMan Real-Time PCR Assay for Direct Detection of Mycobacterium tuberculosis in Respiratory and Nonrespiratory Specimens
Sylvie Armand et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study
Catharina C. Boehme et al.
LANCET (2011)
Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
Armand Van Deun et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Catharina C. Boehme et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Is HIV Infection a Risk Factor for Multi-Drug Resistant Tuberculosis? A Systematic Review
Sujit Suchindran et al.
PLOS ONE (2009)
The competitive cost of antibiotic resistance in Mycobacterium tuberculosis
Sebastien Gagneux et al.
SCIENCE (2006)
Tuberculosis drug resistance: A global threat
JB Nachega et al.
CLINICAL INFECTIOUS DISEASES (2003)
Share Paper
